Thanks to collaboration between a diverse set of clinical CLL research groups, we retrospectively analyzed a total of 1286 CLL cases, identifying 72 of which having presented with an E571 XPO1 mutation at their time of diagnosis. Here, XPO1 is linked to B-cell chronic lymphocytic leukemia.